Showing results (1-10 of 1,820) with videos related to

Sort By:
Pageof 182
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology|July 1, 1997
Neo red cell as an organ preservation solutionY Funakoshi, S Fujita, S Fuchinoue, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
Evaluation of a pyridoxylated hemoglobin polyoxyethylene conjugate solution as a perfusate for small intestine preservationH Liu, T Agishi, T Kawai, et al.
Artificial Organs|April 1, 1994
Complications in blood access for hemodialysisY Nakagawa, K Ota, Y Sato, et al.
Biomaterials, Artificial Cells, and Artificial Organs|January 1, 1988
Long term liver preservation using artificial blood substitutesI Nakajima, S Fuchinoue, S Teraoka, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|January 1, 1992
Usefulness of 31P-MRS as a method of evaluating the viability of preserved and transplanted rat liverY Kanetsuna, S Fujita, T Tojimbara, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 1, 1992
[Evaluation of implantation of a cancer chemotherapeutic vascular access device: report of 91 cases]M Abe, I Nakajima, T Koike, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1992
Modified hemoglobin solution as possible perfusate relevant to organ transplantationT Agishi, K Sonda, I Nakajima, et al.
ASAIO Transactions|July 1, 1988
Forty-eight hour liver preservation using an artificial blood substituteI Nakajima, S Fuchinoue, S Teraoka, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1976
Is hollow fibre occlusion due to maldistribution of blood?T Agishi, K Ota, Y Nose
Pageof 182